January 7, 2007 |
EVERY YEAR SINCE 1996, the online salon Edge has e-mailed a question to scientists and thinkers about the state of the world. This year's question was: "What are you optimistic about?" Below are excerpts of some of the responses. For full responses (and those of other contributors), go to www.edge.org.
December 13, 2000 |
Leaders of the publicly led drive to crack the human genetic code have quietly refused to submit the research paper describing their findings to the same scientific journal as their private-sector rivals, puncturing a truce announced with great fanfare in June by President Clinton. The move revives one of the fiercest rivalries of modern science, which pits the publicly led Human Genome Project against biotech upstart Celera Genomics.
May 30, 2011 |
Instead of sending its employees to space, NASA is building them an office of the future closer to home. The curvy, space-age building at NASA's Ames Research Center in Silicon Valley incorporates technology used by astronauts and will be one of a few structures in the state that can generate more electricity than it consumes. Construction won't be complete until mid-July, but the federal government is already calling the $20-million facility its green building of the year. It has a name only government officials could love — the Sustainability Base — but it is generating a lot of buzz among businesses and government agencies trying to be more green.
June 27, 2000 |
Everybody has a particular way of entering a room. Francis Collins' is to come in quietly behind controversial figures. In 1992, Collins took charge of the publicly led Human Genome Project after James D. Watson, the voluble co-discoverer of DNA's structure, quit in a spat with his government superiors. He was pushed farther into the limelight when J. Craig Venter, the mercurial president of Celera Genomics, announced his determination to beat Collins' team to cracking the genetic code.
December 8, 2000 |
The prestigious journal Science is on the verge of striking an unusual bargain: In return for the right to publish a path-breaking paper on the human genetic code, it would allow the paper's biotech company authors to make their supporting data accessible only to those who promise not to use them for commercial or certain other purposes.
April 5, 2000 |
Monsanto Co. said Tuesday that it has completed "a working draft" of the genetic code of the rice plant--paving the way for improved nutrition, crop yields and drought tolerance, traits needed to feed a growing world population. It is the first plant genome to reach this advanced stage of completion, and scientists say it is especially significant because almost half of the world's people, most of them in Asia, depend on rice as the main staple in their diet.
April 7, 2000 |
A biotech company announced Thursday that it has deciphered the genome of a human volunteer, claiming a scientific first that was greeted by both praise and skepticism from academic scientists who point out that the job remains unfinished. Celera Genomics, in a race with a public effort to map the human genetic code, said it has decoded millions of DNA fragments extracted from an anonymous person--the first phase of its effort to put together a so-called working draft of the genome.
CALIFORNIA | LOCAL
April 11, 1994
The early discoverers of and experimenters with electricity could hardly have imagined how their work would ultimately transform the world. A similar technological upheaval awaits us now as private business starts to exploit the revolution in molecular biology to bring new cures, therapies and we-know-not-what. Just four decades after James D. Watson and Francis H. C.
January 11, 2000 |
A private company that is racing to be the first to map the human genome claimed Monday that it has now deciphered more than 90% of the material that goes into the human genetic code--a signal that the search for the Holy Grail of biotechnology is likely to be completed in a matter of months. Celera Genomics Group, a Rockville, Md., subsidiary of PE Corp., said it expects to have a "rough draft" of the entire code by early summer.
February 12, 2001 |
If you think about the genetics of cancer, it's no wonder that chemotherapy doesn't always work. Recent books show how, when a therapeutic chemical hits and damages malignant cells, the cells often ignore their own self-destruct mechanism because of a genetic mutation that has made them "deaf" to this command. That's why some scientists have placed their hopes on creating viral "smart bombs" to open their ears.